News
-
-
-
PRESS RELEASE
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
Menarini Group presents updated Phase 2 combination data of Elacestrant in ER+, HER2- metastatic breast cancer patients at 2025 San Antonio Breast Cancer Symposium, showing promising progression-free survival benefits and safety profiles -
PRESS RELEASE
Circular Sovereignty Starts with Waste: How SMX's Identity Layer Reclaims Material Value
SMX introduces molecular verification to transform industrial waste management, increasing recovery rates and enabling circular manufacturing. REDWAVE, CETI, and CARTIF collaborate in this circular system -
-
-
-
-
-